Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
respiratory diseases
Pharma
Sanofi mulls buyout of Insmed and its Brinsupri: Bloomberg
A purchase of Insmed would equip Sanofi with the approved Brinsupri, well on its way to blockbuster status in familiar respiratory territory.
Fraiser Kansteiner
Nov 19, 2026 2:10pm
Sanofi teams up with Special Olympics Unified Football World Cup
Jul 15, 2026 8:05am
Insmed forecasts sales of Brinsupri will reach $1B in 2026
Feb 19, 2026 11:45am
Insmed's Brinsupri comes up short in rhinosinusitis trial
Dec 18, 2025 11:27am
Moderna-backed campaign takes a shot at boosting vaccine uptake
Oct 22, 2025 12:30pm
Savara's lung disease asset hit with FDA refuse-to-file letter
May 27, 2025 10:35am